The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Parathyroidectomy in the Management of Secondary Hyperparathyroidism
Open accessAbstract
Secondary hyperparathyroidism develops in CKD due to a combination of vitamin D deficiency, hypocalcemia, and hyperphosphatemia, and it exists in nearly all patients at the time of dialysis initiation. There is insufficient data on whether to prefer vitamin D analogs compared with calcimimetics, but the available evidence suggests advantages with combination therapy. Calcium derangements, patient adherence, side effects, and cost limit the use of these agents. When parathyroid hormone level persists >800 pg/ml for >6 months, despite exhaustive medical interventions, monoclonal proliferation with nodular hyperplasia is likely present along with decreased expression of vitamin D and calcium-sensing receptors. Hence, surgical parathyroidectomy should be considered, especially if concomitant disorders exist, such as persistent hypercalcemia or hyperphosphatemia, tissue or vascular calcification including calciphylaxis, and/or worsening osteodystrophy. Parathyroidectomy is associated with 15%-57% greater survival in patients on dialysis, and it also improves hypercalcemia, hyperphosphatemia, tissue calcification, bone mineral density, and health-related quality of life. The parathyroidectomy rate in the United States declined to approximately seven per 1000 dialysis patient-years between 2002 and 2011 despite an increase in average parathyroid hormone levels, reflecting calcimimetics introduction and uncertainty regarding optimal parathyroid hormone targets. Hospitalization rates are 39% higher in the first postoperative year. Hungry bone syndrome occurs in approximately 25% of patients on dialysis, and profound hypocalcemia requires high doses of oral and intravenous calcium along with calcitriol supplementation. Total parathyroidectomy with autotransplantation carries a higher risk of permanent hypocalcemia, whereas risk of hyperparathyroidism recurrence is higher with subtotal parathyroidectomy. Given favorable long-term outcomes from observational parathyroidectomy cohorts, despite surgical risk and postoperative challenges, it is reasonable to consider parathyroidectomy in more patients with medically refractory secondary hyperparathyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J., Balkrishnan, R., Bragg-Gresham, J., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,191
Self-citationLondon, G. M. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg414 · Cited by 1,859
Levin, A., Bakris, G. L., Molitch, M., Smulders, M., Tian, J., Williams, L. A., & Andress, D. L. (2007) · Kidney International · doi:10.1038/sj.ki.5002009 · Cited by 1,513
Ketteler, M., Block, G. A., Evenepoel, P., Fukagawa, M., Herzog, C. A., McCann, L., Moe, S. M., Shroff, R., Tonelli, M. A., Toussaint, N. D., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.04.006 · Cited by 1,016
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
The EVOLVE Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205624 · Cited by 971
Kalantar-Zadeh, K., Kuwae, N., Regidor, D. L., Kovesdy, C. P., Kilpatrick, R. D., Shinaberger, C. S., McAllister, C. J., Budoff, M. J., Salusky, I. B., & Kopple, J. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001514 · Cited by 905
Self-citationSecondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options
Cunningham, J., Locatelli, F., & Rodriguez, M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06040710 · Cited by 646
Slatopolsky, E., Finch, J., Denda, M., Ritter, C., Zhong, M., Dusso, A., MacDonald, P. N., & Brown, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118701 · Cited by 511
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
Floege, J., Kim, J., Ireland, E., Chazot, C., Drueke, T., de Francisco, A., Kronenberg, F., Marcelli, D., Passlick-Deetjen, J., Schernthaner, G., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq219 · Cited by 477
IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000
(2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)70008-x · Cited by 400
Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl
Moe, S. M., Chertow, G. M., Coburn, J. W., Quarles, L. D., Goodman, W. G., Block, G. A., DrEke, T. B., Cunningham, J., Sherrard, D. J., Mccary, L. C., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67139.x · Cited by 327
Block, G. A., Bushinsky, D. A., Cheng, S., Cunningham, J., Dehmel, B., Drueke, T. B., Ketteler, M., Kewalramani, R., Martin, K. J., Moe, S. M., et al. (2017) · JAMA · doi:10.1001/jama.2016.19468 · Cited by 317
Tentori, F., Wang, M., Bieber, B. A., Karaboyas, A., Li, Y., Jacobson, S. H., Andreucci, V. E., Fukagawa, M., Frimat, L., Mendelssohn, D. C., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12941213 · Cited by 281
Bleyer, A. J., Burke, S. K., Dillon, M., Garrett, B., Kant, K. S., Lynch, D., Rahman, S. N., Schoenfeld, P., Teitelbaum, I., Zeig, S., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70221-0 · Cited by 274
Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis
McCarthy, J. T., el-Azhary, R. A., Patzelt, M. T., Weaver, A. L., Albright, R. C., Bridges, A. D., Claus, P. L., Davis, M. D. P., Dillon, J. J., El-Zoghby, Z. M., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.025 · Cited by 209
Vascular calcification: Contribution of parathyroid hormone in renal failure
Neves, K.-R., Graciolli, F.-G., dos Reis, L.-M., Graciolli, R.-G., Neves, C.-L., Magalhães, A.-O., Custódio, M.-R., Batista, D.-G., Jorgetti, V., & Moysés, R. M. A. (2007) · Kidney International · doi:10.1038/sj.ki.5002241 · Cited by 205
Komaba, H., Taniguchi, M., Wada, A., Iseki, K., Tsubakihara, Y., & Fukagawa, M. (2015) · Kidney International · doi:10.1038/ki.2015.72 · Cited by 196
Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry
Brandenburg, V. M., Kramann, R., Rothe, H., Kaesler, N., Korbiel, J., Specht, P., Schmitz, S., Krüger, T., Floege, J., & Ketteler, M. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv438 · Cited by 191
Shao, J.-S., Cheng, S.-L., Charlton-Kachigian, N., Loewy, A. P., & Towler, D. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308825200 · Cited by 174 · cited 1×
“teriparatide [PTH (1–34)] in diabetic male LDL receptor– null mice inhibited vascular calcification and aortic osteogenic transformation (17).”
BackgroundFracture Risk after Parathyroidectomy among Chronic Hemodialysis Patients
Rudser, K. D., de Boer, I. H., Dooley, A., Young, B., & Kestenbaum, B. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010022 · Cited by 173
FGF23–parathyroid interaction: implications in chronic kidney disease
Komaba, H., & Fukagawa, M. (2010) · Kidney International · doi:10.1038/ki.2009.466 · Cited by 165
UZAWA, T. (1995) · EMC - Cardiologie-Ang�iologie · doi:10.1016/8756-3282(95)90194-9 · Cited by 163
Block, G. A., Bushinsky, D. A., Cunningham, J., Drueke, T. B., Ketteler, M., Kewalramani, R., Martin, K. J., Mix, T. C., Moe, S. M., Patel, U. D., et al. (2017) · JAMA · doi:10.1001/jama.2016.19456 · Cited by 160
Kalantar‐Zadeh, K., Shah, A. P., Duong, U., Hechter, R. C., Dukkipati, R. B., & Kovesdy, C. P. (2010) · Kidney International · doi:10.1038/ki.2010.189 · Cited by 132
Self-citationInitial Parathyroid Surgery in 606 Patients with Renal Hyperparathyroidism
Schneider, R. A., Slater, E. P., Karakas, E., Bartsch, D. K., & Schlosser, K. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1392-0 · Cited by 116
Chen, L., Wang, K., Yu, S., Lai, L., Zhang, X., Yuan, J., & Duan, W. (2016) · Renal Failure · doi:10.1080/0886022x.2016.1184924 · Cited by 90
Dukkipati, R. B., Kovesdy, C. P., Colman, S., Budoff, M. J., Nissenson, A. R., Sprague, S. M., Kopple, J. D., & Kalantar‐Zadeh, K. (2010) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2009.10.006 · Cited by 78
Self-citationDrüeke, T. B., & Ritz, E. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04520908 · Cited by 74
Cheng, S., Lee, J.-J., Liu, T., Yang, T., Chen, H., Wu, C., & Liu, C. (2013) · Surgery · doi:10.1016/j.surg.2013.08.013 · Cited by 68
Insufficiency of PTH action on bone in uremia
Iwasaki, Y., Yamato, H., Nii‐Kono, T., Fujieda, A., Uchida, M., Hosokawa, A., Motojima, M., & Fukagawa, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001600 · Cited by 49
Goto, S., Komaba, H., & Fukagawa, M. (2008) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfn079 · Cited by 38
Resurgence of parathyroidectomy
Komaba, H., Nakamura, M., & Fukagawa, M. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000326 · Cited by 26
Montenegro, J. L., CORNAGO, I., GALLARDO, I., García-Ledesma, P., Hernando, A., Martínez, I., Muñoz, R. I., & Romero, M. A. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01530.x · Cited by 19
Cited by
Zeng, L., Zou, Q., Huang, P., Xiong, L., Cheng, Y., Chen, Q., Li, Y., He, H., Yi, W., & Wei, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111994 · Cited by 23
Metadata
- Authors
- Lau, W. L., Obi, Y., & Kalantar-Zadeh, K.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2018-03-09
- Volume
- 13
- Issue
- 6
- Pages
- 952-961
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2790419112
- Cited by
- 279
- References
- 34
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.